Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

En-Min Li

Showing results (221-230 of 230) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 230 results.
Theranostics|May 1, 2019
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical SignificanceBin Li, Pan Hong, Can-Can Zheng, et al.
Nature Communications|July 17, 2021
Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancerLi-Yan Li, Qian Yang, Yan-Yi Jiang, et al.
Gastroenterology|February 19, 2018
Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell CarcinomaJian-Jun Xie, Yan-Yi Jiang, Yuan Jiang, et al.
Nature Communications|August 17, 2021
Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targetingWei Liu, Lei Xie, Yao-Hui He, et al.
Nature Communications|September 8, 2018
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progressionYuan Jiang, Yan-Yi Jiang, Jian-Jun Xie, et al.
Cancer Discovery|April 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancersHai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 27, 2016
Updated incidence rates and risk factors of esophageal cancer in Nan'ao Island, a coastal high-risk area in southern ChinaHua-Zhen Tan, Wen-Jie Lin, Jin-Qu Huang, et al.
Nature Genetics|August 24, 2010
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54Li-Dong Wang, Fu-You Zhou, Xue-Min Li, et al.
Nature Genetics|August 18, 2014
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populationsChen Wu, Zhaoming Wang, Xin Song, et al.
Human Molecular Genetics|February 11, 2012
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studiesChristian C Abnet, Zhaoming Wang, Xin Song, et al.
Pageof 23

Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
Theranostics|May 1, 2019
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical SignificanceBin Li, Pan Hong, Can-Can Zheng, et al.
Nature Communications|July 17, 2021
Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancerLi-Yan Li, Qian Yang, Yan-Yi Jiang, et al.
Gastroenterology|February 19, 2018
Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell CarcinomaJian-Jun Xie, Yan-Yi Jiang, Yuan Jiang, et al.
Nature Communications|August 17, 2021
Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targetingWei Liu, Lei Xie, Yao-Hui He, et al.
Nature Communications|September 8, 2018
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progressionYuan Jiang, Yan-Yi Jiang, Jian-Jun Xie, et al.
Cancer Discovery|April 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancersHai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 27, 2016
Updated incidence rates and risk factors of esophageal cancer in Nan'ao Island, a coastal high-risk area in southern ChinaHua-Zhen Tan, Wen-Jie Lin, Jin-Qu Huang, et al.
Nature Genetics|August 24, 2010
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54Li-Dong Wang, Fu-You Zhou, Xue-Min Li, et al.
Nature Genetics|August 18, 2014
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populationsChen Wu, Zhaoming Wang, Xin Song, et al.
Human Molecular Genetics|February 11, 2012
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studiesChristian C Abnet, Zhaoming Wang, Xin Song, et al.
Pageof 23